In order to promote the development of standardized management of pulmonary vascular diseases in Heilongjiang Province, on November 15, the "Inaugural Meeting of the Thrombosis and Pulmonary Vascular Disease Professional Committee of Heilongjiang Medical Promotion Association" sponsored by The Heilongjiang Medical Promotion Association and undertaken by our hospital was held in our hospital. At the meeting, the Professional Committee of Thrombosis and Pulmonary Vascular Disease of Heilongjiang Medical Promotion Association was formally established, Professor Yu Bo, President of cardiovascular disease hospital and director of cardiology department of our hospital, was elected honorary chairman, and Professor Wu Bingxiang, deputy director of the Department of Cardiology of our hospital, was elected as the chairman of the committee. Hu Zhiren, President of Heilongjiang Medical Promotion Association, Hao Tianjun, Vice President of our hospital, Professor Yu Bo and Professor Wu Bingxiang delivered speeches for the meeting, and more than 100 experts from relevant fields in the province attended the meeting. Sun Na, attending physician of the Department of Cardiology of our hospital, presided over the meeting. Professor Wu Bingxiang, chairman of the committee, is the deputy leader of the pulmonary vasculology group of the Cardiovascular Disease Branch of the Chinese Medical Association, and the vice chairman of the Pulmonary Vascular Professional Committee of the Cardiovascular Physician Branch of the Chinese Medical Doctor Association. At the meeting, he said that Heilongjiang Province is a high incidence of cardiovascular and cerebrovascular diseases, and the number of patients with thrombosis and pulmonary vascular diseases is also increasing. With the improvement of examination technology and diagnostic awareness, pulmonary vascular disease is gradually recognized by more and more clinicians, but there is still a relative shortage of pulmonary vascular disease specialists in our province, misdiagnosis and missed diagnosis, and the standardized diagnosis and treatment of pulmonary vascular disease needs to be further popularized and promoted. Therefore, the establishment of this professional committee aims to promote the discipline construction and standardized management of pulmonary vascular disease in our province, actively carry out academic research and exchanges related to pulmonary vascular disease, improve the technical level of thrombosis and pulmonary vascular disease in our province, and make the majority of patients with pulmonary vascular disease more beneficial.
The site of the inaugural meeting
Hu Zhiren, president of the Heilongjiang Provincial Medical Promotion Association, delivered a speech
Hao Tianjun, vice president of our hospital, delivered a speech
Professor Yu Bo, President of cardiovascular hospital and director of the Department of Cardiology of our hospital, delivered a speech
Professor Wu Bingxiang, Deputy Director of the Department of Cardiology of our hospital, delivered a speech
He stressed that this professional committee is composed of cardiology, respiratory medicine, hematology, emergency department, ultrasound, CT room, laboratory department and other multidisciplinary departments, and will regularly hold training courses related to thrombosis and pulmonary vascular diseases, actively popularize and promote the professional knowledge of thrombosis and pulmonary vascular diseases, and provide more academic exchange platforms and opportunities for clinicians.
Vice President Hao Tianjun presented Professor Yu Bo with the honorary chairman certificate of the Thrombosis and Pulmonary Vascular Disease Professional Committee of the Heilongjiang Medical Promotion Association
President Hu Zhiren presented Professor Wu Bingxiang with the certificate of chairman of the Thrombosis and Pulmonary Vascular Disease Professional Committee of the Heilongjiang Medical Promotion Association
Heilongjiang Provincial Medical Association Thrombosis and Pulmonary Vascular Disease Professional Committee Group photo
Experts remind that pulmonary hypertension is a type of pathophysiological syndrome that progressively increases the resistance of pulmonary circulation due to the involvement of pulmonary vascular beds caused by various etiology, and eventually leads to right heart failure and even death. People with diseases of the cardiovascular, respiratory, digestive, blood, and rheumatic immune systems are at potential risk of developing pulmonary hypertension. When chest pain, dyspnea, syncope, hemoptysis, and other symptoms occur, you should see a doctor as soon as possible and undergo initial screening with echocardiography and other related tests. When the examination results show that there is a possibility of pulmonary vascular disease, it is necessary to go to a professional pulmonary vascular diagnosis and treatment center for right heart catheters and other related tests to confirm the disease. At present, with the advent of targeted drugs for pulmonary vascular diseases, the treatment effect and prognosis of patients with pulmonary vascular disease have been greatly improved, and early detection, early diagnosis, and early treatment will greatly improve the prognosis of the disease.
Wen | Li Huahong Cao Yue
Pictures | provided by the department